Assessment of blood glucose profile in type 2 diabetic patients after a one-week treatment with gliclazide 60 mg MR using both the glycaemic Holter method and multiple blood glucose samples.A double-blind, randomized, parallel group, placebo-controlled, exploratory study.

Institut de Recherches Internationales Servier0 sitesNovember 4, 2008

ConditionsType 2 diabetes mellitus MedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitus

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Type 2 diabetes mellitus
Sponsor: Institut de Recherches Internationales Servier
Status: Active, not recruiting
Last Updated: 14 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

November 4, 2008

End Date

TBD

Last Updated

14 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

All

Investigators

Sponsor

Institut de Recherches Internationales Servier

Eligibility Criteria

Inclusion Criteria

•. Type 2 diabetic patients
•. Between 35 and 70 years of age inclusive,
•. Diagnosed with diabetes for at least 3 months,
•. Body Mass Index (BMI) between 24 and 38 kg/m2 inclusive,
•. Currently treated with metformin alone.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range
•F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

•· Pregnancy, breast\-feeding or female of childbearing potential not using appropriate contraception,
•· Special diet or substantial changes in eating habits in the last 3 months,
•. Type 1 diabetes.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Phase 3

Double blind, randomised, comparative, multicentre, parallel-group study design to evaluate the effects of Pioglitazone on cardiovascular risk markers in type 2 diabetes mellitus

ACTRN12608000534381Takeda Italia Farmaceutici S.p.A.100

Recruiting

Phase 4

The comparison of blood glucose profile of diabetic patients who change Insulin Glargine to Insulin Degludec as basal insulin.Diabetes

JPRN-UMIN000009627Diabetes Therapeutics and Research Center, The University of Tokushima25

Not yet recruiting

Phase 1

Comparison of blood glucose control in type 2 diabetics on oral drugs to treat diabetes v/s oral drugs to treat diabetes and home remedies.

CTRI/2018/06/014590Meenakshi Garg

Recruiting

Phase 4

Blood-Glucose reduction in Type 2 Diabetes Patients when using two different DPP-4, alogliptin or sitagliptin during 52-week administratioType 2 diabetes

JPRN-UMIN000007487Biomedis International Ltd Study Management300

Recruiting

Phase 3

Effect of Vitamin C supplementation on Diabetes Mellitus and assessment of salivary vitamin C along with periodontal health.Health Condition 1: null- Diabetics (HbA1c above 6.5%) and Prediabetics (5.7-6.4%)

CTRI/2016/03/006764Dr H N Santosh200